Family-Focused Diabetes Management for Type 2 Diabetes
Trial Summary
What is the purpose of this trial?
A family dyad-focused diabetes self-management for African American adults with type 2 diabetes is a randomized controlled trial (RCT) that aims to test the feasibility, acceptability, and efficacy of a family-dyad focused intervention on glycemic control (hemoglobin A1c) and health-related quality of life (HRQOL) in African American adults with type 2 diabetes (T2D).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Family dyad diabetes intervention for Type 2 Diabetes?
Is the Family-Focused Diabetes Management for Type 2 Diabetes treatment safe for humans?
How is the Family Dyad Diabetes Self-Management Intervention treatment different from other treatments for type 2 diabetes?
Eligibility Criteria
African American adults over 40 with type 2 diabetes and a family member (spouse, adult child, or sibling) who live together can join. Both must speak English and be able to walk. The patient needs an A1c > 7.5% and diagnosed for at least six months. Those with cognitive impairments, advanced conditions, or unclear diabetes diagnosis are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 virtual group sessions on diabetes self-management and family support over 12 weeks
Post-intervention Assessment
Participants are assessed immediately after the intervention for changes in health-related quality of life and diabetes control
Follow-up
Participants are monitored for changes in diabetes control and blood pressure six months after the intervention
Treatment Details
Interventions
- Family dyad diabetes intervention (Behavioral Intervention)